Verge - Model ConVERGE - Drug Discovery Platform
The breadth and depth of our pipeline demonstrates the power of the ConVERGEMplatform. All pipeline programs have been discovered and developed on our proprietary platform.
The ConVERGETM platform addresses diseases where biology is the bottleneck. Our programs target therapeutic areas where:
- Multi-factorial components (genetics, environment, and time) intersect in complex ways to culminate in overt disease
- Animal or cell models do not predict human efficacy
- There is high unmet need, no disease-modifying therapies, or significant shortcomings with existing treatment paradigms
Our end-to-end ConVERGETM discovery platform is a closed-loop machine learning system combining industry-leading proprietary human genomics with advanced computational tools to predict new drugs with a higher probability of clinical success.
Our end-to-end ConVERGETM discovery platform is a closed-loop machine learning system combining industry-leading proprietary human genomics with advanced computational tools to predict new drugs with a higher probability of clinical success.
